- Home
- KRMD vs AMRN Comparison
KRMD vs AMRN Comparison
Compare KRMD & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- AMRN
- Stock Information
- Founded
- KRMD 1980
- AMRN 1989
- Country
- KRMD United States
- AMRN Ireland
- Employees
- KRMD N/A
- AMRN N/A
- Industry
- KRMD Medical/Dental Instruments
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- AMRN Health Care
- Exchange
- KRMD Nasdaq
- AMRN Nasdaq
- Market Cap
- KRMD 126.9M
- AMRN 216.0M
- IPO Year
- KRMD N/A
- AMRN 1993
- Fundamental
- Price
- KRMD $3.29
- AMRN $10.71
- Analyst Decision
- KRMD Strong Buy
- AMRN Sell
- Analyst Count
- KRMD 4
- AMRN 2
- Target Price
- KRMD $4.63
- AMRN $7.00
- AVG Volume (30 Days)
- KRMD 118.8K
- AMRN 117.9K
- Earning Date
- KRMD 05-07-2025
- AMRN 05-07-2025
- Dividend Yield
- KRMD N/A
- AMRN N/A
- EPS Growth
- KRMD N/A
- AMRN N/A
- EPS
- KRMD N/A
- AMRN N/A
- Revenue
- KRMD $35,083,740.00
- AMRN $214,112,000.00
- Revenue This Year
- KRMD $16.50
- AMRN N/A
- Revenue Next Year
- KRMD $15.47
- AMRN $0.89
- P/E Ratio
- KRMD N/A
- AMRN N/A
- Revenue Growth
- KRMD 19.65
- AMRN N/A
- 52 Week Low
- KRMD $1.86
- AMRN $7.00
- 52 Week High
- KRMD $5.05
- AMRN $20.60
- Technical
- Relative Strength Index (RSI)
- KRMD 71.25
- AMRN 57.66
- Support Level
- KRMD $2.51
- AMRN $9.44
- Resistance Level
- KRMD $2.86
- AMRN $11.50
- Average True Range (ATR)
- KRMD 0.19
- AMRN 0.85
- MACD
- KRMD 0.09
- AMRN 0.01
- Stochastic Oscillator
- KRMD 96.12
- AMRN 69.14
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.